24th week of 2016 patent applcation highlights part 8

Patent application number	Title	Published
24th week of 2016 patent applcation highlights part 8
20160166490	COSMETIC COMPOSITION COMPRISING A TERNARY LIPID ASSOCIATION FOR CONTROLLING DRYNESS OF THE SKIN	2016-06-16
20160166491	DEODORANT COMPOSITION AND DEODORANT AGENT	2016-06-16
20160166492	PROCESS FOR MAKING A BENEFIT DELIVERY COMPOSITION	2016-06-16
20160166493	PROCESS FOR MAKING A BENEFIT DELIVERY COMPOSITION	2016-06-16
20160166494	COSMETIC COMPOSITION AND METHOD OF PREPARATION	2016-06-16
20160166495	PERSONAL CARE COMPOSITION COMPRISING SILICONE NETWORK	2016-06-16
20160166496	Sunscreen Formulations Comprising Gemini Surfactants and Silicone Based Surfactants	2016-06-16
20160166497	PERSONAL CARE COMPOSITIONS CONTAINING CROSSLINKED SILICONE POLYMER NETWORKS AND THEIR METHOD OF PREPARATION	2016-06-16
20160166498	ORAL CARE COMPOSITION COMPRISING CANNABINOIDS	2016-06-16
20160166499	LIP GLOSS	2016-06-16
20160166500	NOVEL HERBAL HAIR GROWTH PROMOTERS / HAIR TONIC	2016-06-16
20160166501	ORAL COMPOSITIONS	2016-06-16
20160166502	APPARATUS AND METHOD OF STIMULATING ELEVATION OF GLUTATHIONE LEVELS IN A SUBJECT	2016-06-16
20160166503	NASAL DRUG PRODUCTS AND METHODS OF THEIR USE	2016-06-16
20160166504	HYDROGEL DRUG DELIVERY IMPLANTS	2016-06-16
20160166505	Methods And Compositions For Treatment Of Respiratory Tract Infections	2016-06-16
20160166506	METHOD AND SYSTEM FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH NEBULIZED ANTICHOLINERGIC ADMINISTRATIONS	2016-06-16
20160166507	NANOEMULSIONS OF HYDROPHOBIC PLATINUM DERIVATIVES	2016-06-16
20160166508	Method and Composition for Treating Inflammatory Disorders	2016-06-16
20160166509	SiRNA Phospholipid Conjugate	2016-06-16
20160166510	STABILIZED PROLONGED RELEASE PHARMACEUTICAL COMPOSITION COMPRISING ATYPICAL ANTIPSYCHOTIC	2016-06-16
20160166511	APPETISING MEDICAMENT FOR ORAL ADMINISTRATION IN SOLID FORM	2016-06-16
20160166512	Porous Hollow Fiber Anti-Solvent Crystallization-Based Continuous Method of Polymer Coating on Submicron and Nanoparticles	2016-06-16
20160166513	Nanoparticles and Methods of Producing the Same	2016-06-16
20160166514	USE OF CANNABIDIOL IN THE TREATMENT OF EPILEPSY	2016-06-16
20160166515	USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY	2016-06-16
20160166516	NOVEL CURCUMINOID FORMULATIONS AND RELATED METHODS OF TREATMENT	2016-06-16
20160166517	ABUSE-PROOFED DOSAGE FORM	2016-06-16
20160166518	PROCESS FOR MANUFACTURING PHENYLEPHRINE RESINATE PARTICLES PHENYLEPHRINE RESINATE PARTICLES AND USE OF PHENYLEPHRINE RESINATE PARTICLES IN PHARMACEUTICAL FORMULATIONS	2016-06-16
20160166519	CHEMICAL MOLECULES THAT INHIBIT THE SLICING MECHANISM FOR TREATING DISEASES RESULTING FROM SPLICING ANOMALIES	2016-06-16
20160166520	METHODS AND COMPOSITIONS RELATING TO THE TREATMENT OF VISCERAL FAT AND ASTHMA	2016-06-16
20160166521	Compounds, Compositions and Methods for Treating Oxidative DNA Damage Disorders	2016-06-16
20160166522	TREATMENT OF MEDIUM-CHAIN ACYL-CoA DEHYDROGENASE DEFICIENCY	2016-06-16
20160166523	TOPICAL PHARMACEUTICAL GEL COMPOSITION OF DICLOFENAC SODIUM	2016-06-16
20160166524	TOPICAL PHARMACEUTICAL GEL COMPOSITION OF DICLOFENAC SODIUM	2016-06-16
20160166525	Compositions and Methods for The Treatment of Fatty Acid Metabolism Disorders	2016-06-16
20160166526	COMPOUNDS FOR SUPPRESSING A PERIPHERAL NERVE DISORDER INDUCED BY AN ANTI-CANCER AGENT	2016-06-16
20160166527	Glyceride Composition	2016-06-16
20160166528	COMPOSITIONS CONTAINING MONOACETYLDIACYLGLYCEROL COMPOUND AS AN ACTIVE INGREDIENT FOR PREVENTING OR TREATING RHEUMATOID ARTHRITIS	2016-06-16
20160166529	Formulations for Cathepsin K Inhibitors with Vitamin D	2016-06-16
20160166530	SELECTIVE ANDROGEN RECEPTOR MODULATOR AND METHODS OF USE THEREOF	2016-06-16
20160166531	METHODS AND COMPOSITIONS FOR TREATING CARDIOVASCULAR DISORDERS	2016-06-16
20160166532	CARNITINE PALMITOYLTRANSFERASE 1 INHIBITORS FOR INHIBITION OF PATHOLOGICAL ANGIOGENESIS	2016-06-16
20160166533	SYNERGISTIC COMPOSITIONS AND METHODS FOR POTENTIATING ANTI-OXIDATIVE ACTIVITY	2016-06-16
20160166534	Combination Therapies for the Treatment of Alzheimer's Disease and Related Disorders	2016-06-16
20160166535	Methods for Reducing the Occurrence of Hot Flashes	2016-06-16
20160166536	COMBINATION THERAPY FOR THE TREATMENT OF CANCER	2016-06-16
20160166537	ANTIFUGETACTIC AGENTS FOR THE TREATMENT OF BRAIN CANCERS	2016-06-16
20160166538	ANTIFUGETACTIC AGENTS FOR THE TREATMENT OF BREAST CANCER	2016-06-16
20160166539	A NOVEL COMPOSITION FOR NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)	2016-06-16
20160166540	MODULATORS FOR ATP-BINDING CASSETTE TRANSPORTERS	2016-06-16
20160166541	Methods For Identifying Analgesic Agents	2016-06-16
20160166542	INHIBITOR OF GLUCOSYLCERAMIDE SYNTHASE	2016-06-16
20160166543	STABLE COMBINATION ORAL LIQUID FORMULATION OF MELATONIN AND AN ANTIHISTAMINIC AGENT	2016-06-16
20160166544	ORAL PHARMACEUTICAL FORMULATION OF OMARIGLIPTIN	2016-06-16
20160166545	COMBINATIONS COMPRISING BIPHENYL DERIVATIVES FOR USE IN THE TREATMENT OF HCV	2016-06-16
20160166546	COMBINATORIAL METHODS TO IMPROVE THE THERAPEUTIC BENEFIT OF BISANTRENE AND ANALOGS AND DERIVATIVES THEREOF	2016-06-16
20160166547	Combinations Comprising Tricyclohexadecahexaene Derivatives for Use in the Treatment of Hepatitis C Virus	2016-06-16
20160166548	ISOXAZOLE HYDROXAMIC ACID COMPOUNDS AS LpxC INHIBITORS	2016-06-16
20160166549	BCL6 INHIBITORS AS ANTICANCER AGENTS	2016-06-16
20160166550	Combination Therapies for the Treatment of Alzheimer's Disease and Related Disorders	2016-06-16
20160166551	Solid dispersions comprising tacrolimus	2016-06-16
20160166552	PHARMACEUTICAL COMPOSITION COMPRISING PYRIDONE DERIVATIVES	2016-06-16
20160166553	ANTIMETASTATIC COMPOUNDS	2016-06-16
20160166554	COMPOSITION COMPRISING HYALURONIC ACID AND MEPIVACAINE	2016-06-16
20160166555	Cyclooxygenase Inhibitor and Calcium Channel Antagonist Compositions and Methods for Use in Urological Procedures	2016-06-16
20160166556	METHODS OF TREATING PULMONARY HYPERTENSION	2016-06-16
20160166557	ANTIVIRAL AGENTS	2016-06-16
20160166558	METHOD FOR TREATING A PATIENT AT RISK FOR DEVELOPING AN NSAID-ASSOCIATED ULCER	2016-06-16
20160166559	DEUTERATED ANALOGS OF PRIDOPIDINE USEFUL AS DOPAMINERGIC STABILIZERS	2016-06-16
20160166560	Urea Compounds and Their Use as FAAH Enzyme Inhibitors	2016-06-16
20160166561	ANTIPSYCHOTIC TREATMENT BASED ON DRD2 OR ANKK1 SNP GENOTYPE	2016-06-16
20160166562	DISUBSTITUTED 3,4-DIAMINO-3-CYCLOBUTENE-1,2-DIONE COMPOUNDS FOR USE IN THE TREATMENT OF CHEMOKINE-MEDIATED DISEASES	2016-06-16
20160166563	Anti-Allergy Benzocycloheptathiophene Derivatives	2016-06-16
20160166564	Nicotine Salt with Meta-Salicylic Acid	2016-06-16
20160166565	TREATMENT OF MULTIPLE SCLEROSIS WITH COMBINATION OF LAQUINIMOD AND FLUPIRTINE	2016-06-16
20160166566	SALTS OF 2-AMINO-1-HYDROXYETHYL-8-HYDROXYQUINOLIN-2(1H)-ONE DERIVATIVES HAVING BOTH MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITIES	2016-06-16
20160166567	TREATMENT OF CANCER	2016-06-16
20160166568	METHODS AND COMPOSITIONS FOR CORRECTION OF ORGAN DYSFUNCTION	2016-06-16
20160166569	METHOD FOR TREATING SKIN THICKENING	2016-06-16
20160166570	TREATMENT OR PREVENTION OF NON-INFLAMMATORY NEURONAL DAMAGE FROM BRAIN TRAUMA AND STROKES USING MENTHOL, LINALOOL AND/OR ICILIN	2016-06-16
20160166571	COMBINATION THERAPIES FOR TREATMENT OF CANCER	2016-06-16
20160166572	BENEFICIAL EFFECTS OF Lp-PLA2 INHIBITORS IN TREATMENT OF DIABETIC RETINOPATHY AND AGE-RELATED MACULAR DEGENERATION	2016-06-16
20160166573	COMPOSITIONS AND METHODS FOR TREATMENT AND PREVENTION OF HYPERURICEMIA RELATED HEALTH CONSEQUENCES	2016-06-16
20160166574	MACROCYCLES AS KINASE INHIBITORS	2016-06-16
20160166575	PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS KINASE INHIBITORS	2016-06-16
20160166576	SUBSTITUTED AMIDOPYRAZOLE INHIBITORS OF INTERLEUKIN RECEPTOR-ASSOCIATED KINASES (IRAK-4)	2016-06-16
20160166577	TREATMENT OF PULMONARY FIBROSIS USING AN INHIBITOR OF CBP/CATENIN	2016-06-16
20160166578	METHOD FOR TREATING TYPE I AND TYPE II DIABETES	2016-06-16
20160166579	COMBINATION METHODS FOR TREATING CANCERS	2016-06-16
20160166580	FORMULATION OF SYK INHIBITORS	2016-06-16
20160166581	Method for Treating Equine Metabolic Syndrome, Feline Diabetes and Feline Renal Disease	2016-06-16
20160166582	PROTEASOME INHIBITORS AND USES THEREOF	2016-06-16
20160166583	ONAPRISTONE EXTENDED-RELEASE COMPOSITIONS AND METHODS	2016-06-16
20160166584	COMPOSITIONS AND THEIR USE IN ORAL DOSING REGIMENS	2016-06-16
20160166585	COMPOSITIONS AND THEIR USE IN ORAL DOSING REGIMENS	2016-06-16
20160166586	METHOD FOR TREATING A DEGENERATIVE DISEASE OF THE NERVOUS SYSTEM USING 3-METHOXY-PREGNENOLONE OR DERIVATIVES THEREOF	2016-06-16
20160166587	AMELIORATION OF INTESTINAL FIBROSIS AND TREATMENT OF CROHN'S DISEASE	2016-06-16
20160166588	USE OF EDELFOSINE AND OTHER SYNTHETIC ETHER ALKYL-LYSOPHOSPHOLIPIDS (APLs) FOR SEIZURES AND RELATED DISEASES	2016-06-16
20160166589	Osteoclast Inhibitors Such as Zoledronic Acid for Low Back Pain Treatment	2016-06-16

Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees